FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for LYRICA CR (pregabalin) filed by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Fibromyalgia
• Partial-onset Seizures
• Postherpetic Neuralgia

Drugs mentioned

• LYRICA CR (PREGABALIN)

Snippet

SUPPL AP for LYRICA CR (PREGABALIN)